A prospective evaluation of apolipoprotein M gene T-778C polymorphism in relation to coronary artery disease in Han Chinese

Clinical Biochemistry

Volumn 40, Issue 15, 2007, Pages 1108-1112

  Jiao, Guo qing ^a,b   Yuan, Zhong xiang ^a   Xue, Yong sheng ^b   Yang, Cheng jian ^b   Lu, Cheng bao ^a   Lü ̌, Zhi qian ^a   Xiao, Ming di ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

ApoM; Coronary artery disease; Genetic polymorphism; Risk factor

Indexed keywords

APOLIPOPROTEIN M; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; APOLIPOPROTEINS; BASE SEQUENCE; CASE-CONTROL STUDIES; CHINA; CHOLESTEROL; CORONARY ARTERY DISEASE; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34548493701     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.04.023     Document Type: Article

References (17)

1. Xu N., and Dahlback B. A novel human apolipoprotein (apoM). J. Biol. Chem. 274 (1999) 31286-31290
2. Xu N., Nilsson-Ehle P., and Ahren B. Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects. J. Nutr. Biochem 15 (2004) 579-582
3. Duan J., Dahlback B., and Villoutreix B.O. Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis. FEBS Lett. 499 (2001) 127-132
4. Wolfrum C., Poy M.N., and Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat. Med. 11 (2005) 418-422
5. Ni N., Zhu X., Liu Y., et al. Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese. Diabetes Metab. Res. Rev. 23 (2007) 21-25
6. John S.W., Weitzner G., Rozen R., and Scriver C.R. A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res. 19 (1991) 408
7. Marenberg M.E., Risch N., Berkman L.F., Floderus B., and de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N. Engl. J. Med. 330 (1994) 1041-1046
8. Nora J.J., Lortscher R.H., Spangler R.D., Nora A.H., and Kimberling W.J. Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation 61 (1980) 503-508
9. Guneri S., Baris N., Aytekin D., Akdeniz B., Pekel N., and Bozdemir V. The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus. Int. J. Heart 46 (2005) 889-897
10. Hirashiki A., Yamada Y., Murase Y., et al. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J. Am. Coll. Cardiol. 42 (2003) 1429-1437
11. Baroni M.G., Berni A., Romeo S., et al. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD. BMC Med. Genet. 10 (2003) 4-8
12. 2 polymorphism of the platelet glycoprotein receptor IIb/IIIIa and its correlation with myocardial infarction: an appraisal. Clin. Appl. Thromb./Hemost. 12 (2006) 93-95
13. Yokota M., Ichihara S., Lin T.L., Nakashima N., and Yamada Y. Association of a T29-C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101 (2000) 2783-2787
14. Christoffersen C., Nielsen L.B., Axler O., Andersson A., Johnsen A.H., and Dahlback B. Isolation and characterization of human apolipoprotein M-containing lipoproteins. J. Lipid Res. 47 (2006) 1833-1843
15. Singh K., Batuman O.A., Akman H.O., Kedees M.H., Vakil V., and Hussain M.M. Differential, tissue-specific, transcriptional regulation of apolipoprotein B secretion by transforming growth factor beta. J. Biol. Chem. 277 (2002) 39515-39524
16. Xu N., Hurtig M., Zhang X.Y., Ye Q., and Nilsson-Ehle P. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells. Biochim. Biophys. Acta 1683 (2004) 33-37
17. Xu N., Zhang X.Y., Dong X., Ekstrom U., Ye Q., and NilssonEhle P. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1 alpha on the expression of apolipoprotein M in HepG2 cells. Biochem. Biophys. Res. Commun. 292 (2002) 944-950